These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Quercitrin inhibits platelet activation in arterial thrombosis. Oh TW; Do HJ; Jeon JH; Kim K Phytomedicine; 2021 Jan; 80():153363. PubMed ID: 33070081 [TBL] [Abstract][Full Text] [Related]
6. Energy metabolism in platelets fuels thrombus formation: Halting the thrombosis engine with small-molecule modulators of platelet metabolism. Kulkarni PP; Ekhlak M; Dash D Metabolism; 2023 Aug; 145():155596. PubMed ID: 37244415 [TBL] [Abstract][Full Text] [Related]
7. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling. Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin. Mosawy S; Jackson DE; Woodman OL; Linden MD Platelets; 2013; 24(8):594-604. PubMed ID: 23249183 [TBL] [Abstract][Full Text] [Related]
9. Metabolic plasticity in resting and thrombin activated platelets. Ravi S; Chacko B; Sawada H; Kramer PA; Johnson MS; Benavides GA; O'Donnell V; Marques MB; Darley-Usmar VM PLoS One; 2015; 10(4):e0123597. PubMed ID: 25875958 [TBL] [Abstract][Full Text] [Related]
10. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956 [TBL] [Abstract][Full Text] [Related]
11. Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α Hsia CH; Lu WJ; Lin KH; Chou DS; Geraldine P; Jayakuma T; Chang NC; Sheu JR J Cell Mol Med; 2018 Apr; 22(4):2142-2152. PubMed ID: 29369482 [TBL] [Abstract][Full Text] [Related]
12. Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Woulfe DS; Lilliendahl JK; August S; Rauova L; Kowalska MA; Abrink M; Pejler G; White JG; Schick BP Blood; 2008 Apr; 111(7):3458-67. PubMed ID: 18094327 [TBL] [Abstract][Full Text] [Related]
13. Platelet Shp2 negatively regulates thrombus stability under high shear stress. Hu M; Liu P; Liu Y; Yue M; Wang Y; Wang S; Chen X; Zhou Y; Zhou J; Hu X; Ke Y; Hu H J Thromb Haemost; 2019 Jan; 17(1):220-231. PubMed ID: 30444570 [TBL] [Abstract][Full Text] [Related]
18. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation. Endale M; Lee WM; Kamruzzaman SM; Kim SD; Park JY; Park MH; Park TY; Park HJ; Cho JY; Rhee MH Br J Pharmacol; 2012 Sep; 167(1):109-27. PubMed ID: 22471932 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase. Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810 [TBL] [Abstract][Full Text] [Related]
20. Full activation of mouse platelets requires ADP secretion regulated by SERCA3 ATPase-dependent calcium stores. Elaïb Z; Adam F; Berrou E; Bordet JC; Prévost N; Bobe R; Bryckaert M; Rosa JP Blood; 2016 Aug; 128(8):1129-38. PubMed ID: 27301859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]